Multiomics and machine learning in cholangiocarcinoma: A paradigm shift toward molecular subtyping and precision therapy.

Journal: Hepatology (Baltimore, Md.)
Published Date:

Abstract

No abstract available for this article.

Authors

Keywords

No keywords available for this article.